Navigation Links
MannKind Corporation to Hold Third Quarter Financial Results Conference Call on November 5, 2008
Date:10/29/2008

VALENCIA, Calif., Oct. 29 /PRNewswire-FirstCall/ -- MannKind Corporation (Nasdaq: MNKD) will release its 2008 third quarter financial results on Wednesday, November 5, 2008 at 8:00 a.m. EST.

Management of the Company will host a conference call to discuss the third quarter financial results, clinical progress and other Company developments at 9:00 a.m. EST on November 5, 2008. Presenting from the Company will be its Chairman and Chief Executive Officer, Alfred Mann; President and Chief Operating Officer, Hakan Edstrom; Corporate Vice President and Chief Financial Officer, Matthew Pfeffer and Corporate Vice President and Chief Scientific Officer, Peter Richardson.

To participate in the live call by telephone, please dial (888) 677-5721 or (210) 839-8507. Those interested in listening to the conference call live via the Internet may do so by visiting the Company's website at http://www.mannkindcorp.com.

A telephone replay of the call will be accessible for approximately fourteen days following completion of the call by dialing (866) 411-1707 or (202) 369-0654. A replay will also be available on MannKind's website for fourteen days.

About MannKind Corporation

MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes and cancer. Its pipeline includes AFRESA(TM), which has completed Phase 3 clinical trials, and MKC253, which is c
'/>"/>

SOURCE MannKind Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. MannKind Unveils Proposed Trade Name at Dedication of Danbury Manufacturing Facility
2. MannKind to Present at the UBS Global Life Sciences Conference
3. MannKind Corporation Reports Second Quarter Financial Results
4. MannKind Corporation to Hold Second Quarter Financial Results Conference Call on August 11, 2008
5. MannKind to Present at Upcoming Conferences
6. MannKind Corporation Reports First Quarter Financial Results
7. MannKind to Present at the Morgan Stanley Healthcare Conference
8. MannKind Corporation to Hold First Quarter Financial Results Conference Call on May 5, 2008
9. Matthew J. Pfeffer Joins MannKind as Corporate Vice President and Chief Financial Officer
10. MannKind Corporation Response to Recent Market Events
11. MannKind Corporation to Hold Fourth Quarter Financial Results Conference Call on March 4, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2015)... , July 24, 2015 ... equities: PDL BioPharma Inc. (NASDAQ: PDLI ), Arena ... STEM ), Northwest Biotherapeutics Inc. (NASDAQ: NWBO ... Free research report on PDL BioPharma can be accessed ... the NASDAQ Composite ended at 5,146.41, down 0.49%, the ...
(Date:7/24/2015)... , July 24, 2015 Orexigen Therapeutics, Inc. ... results for the second quarter 2015 on Thursday, August ... will provide a business update and discuss the financial ... 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time). ... by calling (800) 447-0521 (domestic) or (847) 413-3238 (international), ...
(Date:7/24/2015)... July 24, 2015 The global ... reach USD 27.8 billion by 2022, growing at an ... to a new study by Grand View Research, Inc. ... expected to result in significant reduction in cost of ... adoption and usage rates of next generation sequencing throughout ...
(Date:7/24/2015)... ... July 24, 2015 , ... ... any modern scientific or pharmaceutical laboratory. FreezerPro® is an intuitive, fast, reliable ... where a sample is located even before opening the freezer door! Popular ...
Breaking Biology Technology:Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 2Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 3Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 4Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 5Next Generation Sequencing (NGS) Market To Reach $27.8 Billion By 2022: Grand View Research, Inc. 2Next Generation Sequencing (NGS) Market To Reach $27.8 Billion By 2022: Grand View Research, Inc. 3Next Generation Sequencing (NGS) Market To Reach $27.8 Billion By 2022: Grand View Research, Inc. 4Next Generation Sequencing (NGS) Market To Reach $27.8 Billion By 2022: Grand View Research, Inc. 5RURO, Inc. Partners with Integrated Systems Engineering to Provide Comprehensive LIMS Software to Biobanks 2RURO, Inc. Partners with Integrated Systems Engineering to Provide Comprehensive LIMS Software to Biobanks 3RURO, Inc. Partners with Integrated Systems Engineering to Provide Comprehensive LIMS Software to Biobanks 4
... Sunflower Oils drive better restaurant menu optionsINDIANAPOLIS, Feb. 25 ... milestone in North America with the reduction of nearly ... over the past three years. Since the market introduction ... Dow AgroSciences, have replaced more than 340 million pounds ...
... the preclinical development of CureDM,s HIP2B peptide targeted for the treatment of ... ... February 25, 2009 -- Calvert Research, LLC (a Calvert ... with CureDM to continue the preclinical development of CureDM,s HIP2B ...
... into mouse and human patients, researchers at VIB connected to ... same gene suppresses cancer in all three. Reciprocally, switching off ... a good chance that the gene can be switched on ... reputed scientific journal PLoS Biology . , , Specialized ...
Cached Biology Technology:Heart Health Month Milestone: Half a Billion Pounds of Bad Fats Eliminated From North American Diet 2Heart Health Month Milestone: Half a Billion Pounds of Bad Fats Eliminated From North American Diet 3Calvert Research and CureDM Sign Collaborative Agreement 2Calvert Research and CureDM Sign Collaborative Agreement 3Anti-cancer gene discovered: Perspective for therapy 2
(Date:7/8/2015)... , July 8, 2015  Trovagene, Inc. ... molecular diagnostics, today announced the launch of a ... Company,s Precision Cancer Monitoring℠ (PCM) technology for predicting ... one or a combination of the novel immunotherapy ... (nivolumab), a PD-1 inhibitor. The 50-patient study will ...
(Date:7/2/2015)... June 25, 2015 ... addition of the "Natural Language Processing Market ... IVR, OCR, Pattern & Image Recognition) - Worldwide ... The key vendors occupying the market ... Corporation, Microsoft Corporation, NetBase Solutions, SAS Institute Inc., ...
(Date:6/29/2015)... 24, 2015 Research and ... "Latin America Biomedical Sensors Market - Growth, Trends ... The Latin America Biomedical Sensors market is estimated ... 2.04% over the period 2014-2020 The near ... the genetic formulation of each individual. These sensors can ...
Breaking Biology News(10 mins):Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2Latin America Biomedical Sensors Market Report 2015-2020 2
... climate shows that the Sahel region, which experienced catastrophic ... wetter monsoons for decades to come. However, drought across ... consistent with an increase in greenhouse gases appears to ... Africa's monsoons. , James Hurrell of the National Center ...
... centimetre-long nails spoke volumes. But now definitive corroborating DNA evidence ... grizzly bear. The discovery fuels mounting evidence that Canada's High ... bear -- Nanuk is having to make room for its ... bear (Ursus arctos) was discovered on Melville Island, an uninhabited ...
... whales, found during the summer in Alaska waters, is one ... Commercial whaling in the 1800s has now left us with ... as a different species from right whales seen in the ... help define areas and ecological parameters critical to the survival ...
Cached Biology News:Africa to take it on chin again with climate change 2Africa to take it on chin again with climate change 3Grizzlies set to invade high Arctic? 2Habitat use by North Pacific right whales, Eubalaena japonica, in the Bering Sea and Gulf of Alaska 2
... trays are disposable trays that ... that have been blotted onto ... eight 10.5 cm x 5 ... cut from blotted membrane and ...
... and experiment control software. Records waveform, ... and off-line analysis. powerful stimulus generation ... allowing the user to customize the ... range from basic data logging to ...
... • Small design specifically for western blots ... are specifically designed for staining western blots. ... 25 mm) of the disposable tray requires ... significant cost savings to the user. Pour ...
... pLivSelect is a ... for recombinant identification. Recombinant ... colony survival, eliminating the ... screening. This quick and ...
Biology Products: